Table 3 Combination rates of chemotherapy and these regimens
From: Multi-Institutional Analysis of Early Glottic Cancer from 2000 to 2005
| Â | T1a | T1b | T2 |
|---|---|---|---|
Combination rate (%) | 23†| 22††| 60 |
Regimen (n) | |||
 Low dose CDDP (daily) | 0 | 1 | 6 |
 Low dose CDDP/5FU (daily) | 0 | 1 | 2 |
 High dose CDDP/5FU | 9 | 5 | 17 |
 Carboplatin (daily) | 1 | 0 | 0 |
 Carboplatin (weekly) | 4 | 1 | 12 |
 CDDP/5FU/DTX | 0 | 0 | 5 |
 DTX (Docetaxel) | 1 | 0 | 2 |
 UFT (oral antidrug) | 12 | 5 | 6 |
 TS-1 (oral antidrug) | 1 | 1 | 0 |